GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (LSE:POLB) » Definitions » Net Income Including Noncontrolling Interests

Poolbeg Pharma (LSE:POLB) Net Income Including Noncontrolling Interests : £-5.79 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Poolbeg Pharma's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2024 was £-3.53 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 was £-5.79 Mil.

Poolbeg Pharma Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Poolbeg Pharma's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Net Income Including Noncontrolling Interests Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
-2.34 -4.69 -3.93 -5.79

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial -3.08 -1.81 -2.12 -2.26 -3.53

Poolbeg Pharma Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-5.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (LSE:POLB) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
LSE:IMM LSE:IXI LSE:OPTI LSE:AREC AQSE:PBX LSE:APTA LSE:CIZ LSE:HEMO LSE:FAB AQSE:INC VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
POLBF:USA 7JN:Germany
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Website
https://www.poolbegpharma.com
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines